FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND
PensionPosition in RPRX — Royalty Pharma plc
CIK 1540880
STOCKHOLM, V7
Position in RPRX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$9,988,870
+$1,917,918 QoQ
Shares Held
178,150
+5.9% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#156
of 641 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND holds $168,902,807 across 7 Biotechnology names. RPRX ranks #6 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
148,682 | $73,854,809 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,742 | $26,651,346 | |
| 3 | INCY |
Incyte Corp
|
179,969 | $20,401,285 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
66,985 | $20,164,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
56,300 | $10,543,864 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
178,150 | $9,988,870 | |
| 7 | INSM |
INSMED Inc
|
68,450 | $7,298,139 |
All Filings in RPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,988,870 | 178,150 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $8,070,952 | 168,250 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $4,573,044 | 118,350 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,316,508 | 122,350 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $4,274,959 | 118,650 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,725,431 | 87,550 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,228,290 | 126,550 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $2,411,722 | 85,250 | Shares | Sole | 2024-11-08 | |
| 2024-03-31 | $2,871,483 | 94,550 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,198,046 | 113,850 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,221,409 | 81,850 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $2,734,323 | 88,950 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $4,775,776 | 132,550 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,078,464 | 103,200 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,391,674 | 109,300 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,594,972 | 109,300 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,528,424 | 141,900 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,801,925 | 120,500 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,273,206 | 62,900 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,549,578 | 62,200 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,909,454 | 66,700 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,122,120 | 42,400 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||